Italy · AIFA medicine catalogue

BREYANZI

A source-listed package record. Different packs may share the same medicine name.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
050053014
Form
Dispersione per infusione
Composition / generic term
LISOCABTAGENE MARALEUCEL
Company as listed by source
BRISTOL-MYERS SQUIBB PHARMA EEIG
Source status
Autorizzata
Supply classification
Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile

Source-listed ingredients

  • LISOCABTAGENE MARALEUCEL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1,1-70 ? 10 alla sesta cellule/mL / 1,1-70 ? 10 alla sesta cellule/mL - Dispersione per infusione - Uso endovenoso - Flaconcino (COC) 4,6 mL per flaconcino - Da 1 a 4 flaconcini di ciascun componente cellulare

Source and coverage

Open AIFA medicine catalogue

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Italy records →